Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Símbolo de cotizaciónCHEK
Nombre de la empresaCheck Cap Ltd
Fecha de salida a bolsaFeb 19, 2015
Director ejecutivoMr. Alex Ovadia
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 19
Dirección29 Abba Hushi Ave.
Ciudad
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísIsrael
Código postal3009000
Teléfono97248303401
Sitio Webhttps://check-cap.com/
Símbolo de cotizaciónCHEK
Fecha de salida a bolsaFeb 19, 2015
Director ejecutivoMr. Alex Ovadia
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos